Long-Term Treatment with Lenalidomide in Previously Treated Subjects with Multiple Myeloma

被引：0
|
作者：
Amor, A. A. [1 ]
Aguado, B. [1 ]
Camara, C. [1 ]
Velasco, A. [1 ]
Garcia-Escribano, F. [1 ]
机构：
[1] Hosp Univ Princesa, Dept Hematol, Madrid, Spain
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70580-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S68 / S69
页数：2
相关论文
共 50 条
  • [31] Lenalidomide in the treatment of multiple myeloma
    Rao, Kamakshi V.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (17) : 1799 - 1807
  • [32] EFFICACY AND SAFETY OF THE TREATMENT WITH LENALIDOMIDE IN LONG TERM IN PATIENTS WITH MULTIPLE MYELOMA. EXPERIENCE OF A CENTRE
    Saucedo Alejandro, Marin
    Ana, Sanchez
    Pablo, Rios
    Joaquin, Brena
    Cristina, Notario
    Hector, Gonzalez
    Ana, Cabello
    Carmen, Marrero
    Nuria, Hernanz
    Ana, Oliva
    Antonio, Leon
    Mario, Rios
    Alexander, Figueroa
    Patricia, Hernandez
    Yaxiraxi, Lorenzo
    Maria Carmen, Mesa
    HAEMATOLOGICA, 2016, 101 : 305 - 305
  • [33] Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible
    Engelhardt, Monika
    Kortuem, K. Martin
    Goldschmidt, Hartmut
    Merz, Maximilian
    HAEMATOLOGICA, 2024, 109 (08) : 2420 - 2435
  • [34] Long-term survival in multiple myeloma
    Joao, Cristina
    Costa, Carlos
    Coelho, Ines
    Vergueiro, Maria Joao
    Ferreira, Mafalda
    da Silva, Maria Gomes
    CLINICAL CASE REPORTS, 2014, 2 (05): : 173 - 179
  • [35] Long-term survivors in multiple myeloma
    Vasilica, M
    Coriu, D
    Colita, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1150 - 1150
  • [36] The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib
    Richardson, Paul G.
    Laubach, Jacob P.
    Schlossman, Robert L.
    Ghobrial, Irene M.
    Redman, Katherine C.
    Mckenney, Mary
    Warren, Diane
    Noonan, Kimberly
    Lunde, Laura
    Doss, Deborah
    Colson, Kathleen
    Hideshima, Teru
    Mitsiades, Constantine
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (05) : 446 - 449
  • [37] Erratum: Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    I N M Micallef
    A D Ho
    L M Klein
    S Marulkar
    P J Gandhi
    G Calandra
    P A McSweeney
    Bone Marrow Transplantation, 2011, 46 : 1398 - 1398
  • [38] Long-Term Follow-up of Multiple Myeloma Patients Treated by VELCADE
    Michallet, M.
    Sobh, M.
    Le, Q. H.
    Barraco, F.
    Dumontet, C.
    Plesa, C.
    Chelghoum, Y.
    Cannas, G.
    Virelizier, E. N.
    Thomas, S.
    Praire, A.
    Nicolini, F. E.
    Troncy, J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S11 - S11
  • [39] LONG-TERM FOLLOW-UP OF MULTIPLE MYELOMA PATIENTS TREATED BY VELCADE
    Michallet, M.
    Sobh, M.
    Le, Q. -H.
    Barraco, F.
    Nicolini, F. E.
    Dumontet, C.
    Chelghoum, Y.
    Thomas, X.
    Cannas, G.
    Nicolas-Virelizier, E.
    Plesa, N.
    Ducastelle, S.
    Troncy, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 618 - 619
  • [40] Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long-Term Follow-Up
    Sharma, Nidhi
    Chen, David T.
    Zhao, Qiuhong
    Williams, Nita Y.
    Rosko, Ashley
    Benson, Don M.
    Chaudhry, Maria
    Bumma, Naresh
    Khan, Abdullah
    Devarakonda, Srinivas
    Hofmeister, Craig C.
    Sborov, Douglas
    Efebera, Yvonne A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (01) : 44 - 49
12345